Science, politics, and the GM debate in Europe.
Europe today stands at a crossroad, facing challenges but also opportunities. In its intent to make Europe a leading technology-based economy by 2010, the European Commission has identified biotechnology and genomics as fields for future growth, crucial for supporting the agricultural and food processing industry. Since first commercialization in 1996, GM crop areas have grown at double-digit rates, making this one of the most rapidly adopted technologies in agriculture. However, in contrast to other world areas and despite European Commission support, Europe has found itself 'bogged-down' in a polemic between opponents and supporters of plant biotechnology. As a result, planted areas have remained small. This stalemate is due to a lack of political leadership, especially at the Member State level, all the more surprising in light of European early development and competitive advantage with crop biotechnology. This situation proves once again that, for cutting-edge innovations, a solid science base alone is not sufficient. Acceptance or rejection of new technologies depends on interlinked political, economic, and societal factors that create a favorable or unfavorable situation at a given time. This article will look at GM crops in Europe and the role science and politics have played in the introduction of crop biotechnology.
Tencalla
Francesca
F
Monsanto Europe S.A., Avenue de Tervuren 270-272, B-1150 Brussels, Belgium. francesca.tencalla@monsanto.com
D001709:Biotechnology / Q000191:economics; D018556:Crops, Agricultural / Q000235:genetics*; D005060:Europe; D030841:Food, Genetically Modified; D005818:Genetic Engineering; D033161:Government Regulation; D030821:Plants, Genetically Modified; D011057:Politics; D012586:Science